Patient Square Capital has successfully acquired Premier, Inc. for $2.6 billion, marking a significant investment in the technology-driven health care improvement sector.

About the Target: Premier, Inc.

Premier, Inc., headquartered in Charlotte, North Carolina, is a leading technology-driven health care improvement company recognized for uniting providers, suppliers, payers, and policymakers. Through its innovative services and solutions, Premier aims to enhance the quality of health care across the nation. The company offers integrated data and analytics, collaboratives, supply chain solutions, and consulting services to fulfill its mission of improving community health.

The company has recently been acquired by Patient Square Capital, with the deal valued at $2.6 billion. Following this acquisition, Premier's common stock has ceased trading and will be delisted from Nasdaq as of November 25, 2025. As part of the transaction, Premier stockholders will receive $28.25 in cash for each share they hold.

Industry Overview in the United States

The health care industry in the United States is undergoing significant transformation, driven by technological advancements and increasing demands for efficient, patient-centric care. A growing focus on data analytics and integrated care

View Source

Similar Deals

Bambu Ventures Lemonaid Health

2026

Buyout Advanced Medical Equipment & Technology (NEC) United States of America
Heartland Dental Smile Design Dentistry

2025

Buyout Hospitals, Clinics & Primary Care Services United States of America
Sun Pharmaceutical Industries Limited Checkpoint Therapeutics, Inc.

2025

Buyout Proprietary & Advanced Pharmaceuticals United States of America
Court Square Capital and WindRose Health Investors Soleo Health

2025

Buyout Healthcare Facilities & Services (NEC) United States of America
Supernus Pharmaceuticals, Inc. Sage Therapeutics, Inc.

2025

Buyout Proprietary & Advanced Pharmaceuticals United States of America
SERB Pharmaceuticals Y-mAbs Therapeutics

2025

Buyout Proprietary & Advanced Pharmaceuticals United States of America

Patient Square Capital

invested in

Premier, Inc.

in 2025

in a Buyout deal

Disclosed details

Transaction Size: $2,600M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert